October 7, 2008 – CeloNova BioSciences Inc. will showcase the technology behind the CATANIA Coronary Stent System ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.Â
October 1, 2008 - Boston Scientific Corp. said today the U.S. District Court in Delaware has entered judgment against ...
September 30, 2008
September 30, 2008 – Czech Republic-based Tryton Medical Inc. said today it launched a novel Side Branch Stent System in ...
September 29, 2008Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023September 25, 2008 - Boston Scientific Corp. announced it has received approval from the FDA to market its TAXUS ...
September 24, 2008September 19, 2008 – Last month, MIV announced continued positive results for VESTAsync, a polymer-free drug-eluting ...
September 18, 2008September 19, 2008 - Boston Scientific Corp. announced this week a decision by the U.S. District Court in Delaware ...
September 18, 2008September 17, 2008 - Medtronic Inc. said this week it started two new trials of the Endeavor Resolute drug-eluting stent ...
September 16, 2008
IDev Technologies’ SUPERA interwoven nitinol self-expanding stent is designed for palliative treatment of malignant ...
September 11, 2008September 11, 2008 -Cook Medical has completed enrollment in the first international clinical trial of a first-of ...
September 10, 2008The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System.
Boston Scientific ...
September 09, 2008September 5, 2008 - The results of the SYNTAX study, a head-to-head comparison between drug-eluting stents (DES) using ...
September 04, 2008The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System and Abbott Vascular’s ...
September 03, 2008Feature | Venkat Rajan, medical research analyst, Frost & Sullivan
This comparison chart features three categories of stents: coronary, carotid and peripheral. We gratefully acknowledge ...
September 03, 2008September 2, 2008 - The safety debate about drug-eluting stents (DES) is still ongoing and in these times of uncertainty ...
September 02, 2008September 2, 2008 – Boston Scientific Corp. today announced positive one-year results from the European and ...
September 01, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now